Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Nanobiotix S.A.

< Previous 1 2 Next >
NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Voting Rights and Shares Capital of the Company
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Voting Rights and Shares Capital of the Company
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX to Participate in Multiple Investor Conferences in November
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Voting Rights and Shares Capital of the Company
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Voting Rights and Shares Capital of the Company
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Voting Rights and Shares Capital of the Company
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Voting Rights and Shares Capital of the Company
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Voting Rights and Shares Capital of the Company
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
NANOBIOTIX to Announce Fourth Quarter and Full Year 2023 Operational and Financial Update on April 24, 2024
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Voting Rights and Shares Capital of the Company
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Nanobiotix to Present at Upcoming Investor Conferences in March
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Voting Rights and Shares Capital of the Company
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Nanobiotix to Present at the Guggenheim 6th Annual Biotechnology Conference
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
Nanobiotix Announces Achievement of $20M Development Milestone Payment Related to Ongoing Global Phase 3 Head and Neck Cancer Study
From Nanobiotix S.A.
Via GlobeNewswire
Tickers NBTX
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback